Search - tctmd.com

Displaying 641 - 660 of 2472

Sort: Relevancy | Date

Presentation TCT 2015

Transcatheter Valve Implantation in the IVC/SVC for Tricuspid Regurgitation

Presenter: Rebecca T. Hahn, Joachim Schofer, Hans R. Figulla

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Presenter: John D. Carroll, Ioanna Kosmidou, Howard C. Herrmann

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

TCT 110: Up-to-1-Year Follow-up Results of the Transcatheter Annuloplasty Ring Multicentre Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Presenter: Steven R. Bailey, Patrick W. Serruys, Federico De Marco

October 15, 2015

Presentation TCT 2015

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

Presenter: Greg L. Kaluza, Joachim Schofer, Miriam Silaschi

October 15, 2015

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: Danny Dvir

October 15, 2015

Presentation TCT 2015

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Thierry Lefevre

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Presenter: Howard C. Herrmann

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Advertisement

Transcatheter Valve Implantation in the IVC/SVC for Tricuspid Regurgitation

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

TCT 110: Up-to-1-Year Follow-up Results of the Transcatheter Annuloplasty Ring Multicentre Trial

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content